Skip to main content
Year archive

ViGenCell Inc. — 2023 filings

All 15 regulatory filings released by ViGenCell Inc. (308080) in 2023, sourced directly from the official regulator.

15 Filings
2023 Period
2023 filings (15)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-14 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-12-13 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-10-30 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-06-15 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-23 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-15 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-07 Korean
주주총회소집결의
AGM Information
2023-02-22 Korean
투자판단관련주요경영사항(재발성 교모세포종 치료제 VT-Tri(2)의 식품의약품안전처 제1상 임상시험계획(IND) 자진취하)
Legal Proceedings Report
2023-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-08 Korean